1
0
0
(1 - 17 von 17
)
Targeted Therapies in Cancer | E-kirja - Ellibswww.ellibs.com › book › targeted-therapies-in-cancer
www.ellibs.com
142,95 €Jan Siehl, Eckhard Thiel Antibody Therapy in Non-Hodgkin's Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, and Alemtuzumab Thomas Fietz ,95 € Jan Siehl, Eckhard Thiel Antibody Therapy in Non-Hodgkin's Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, and Alemtuzumab Thomas Fietz ...
Targeted Therapies in Cancer - Seite xiv - Google Books-Ergebnisseitegoogle.ch
books.google.ch
... Jan Siehl, MD Medizinische Klinik III (Hematology, Oncology and Transfusion Medicine) Charité Campus Benjamin Franklin Hindenburgdamm Berlin ...
Targeted Therapies in Cancer - Google Books
books.google.co.ve
From its introduction, oncological chemotherapy has been encumbered by its poor selectivity because most antiproliferative drugs are toxic not only to tumor...
Targeted Therapies in Cancer - Seite xiv - Google Books-Ergebnisseite
books.google.de
... MD Department of Hematology and Oncology Charité Universitätsmedizin Berlin Berlin Germany Jan Siehl, MD Medizinische Klinik III (Hematology, ...
Targeted Therapies In Cancer | PDF - SlideSharewww.slideshare.net › fovak › targeted-therapies-in-cancer
www.slideshare.net
... Jan Siehl, Eckhard Thiel 13 Antibody Therapy in Non-Hodgkin's Lymphoma: The ... Jan Siehl, MD Berlin Medizinische Klinik III (Hematology, Oncology ...
in Cancer Research
content.e-bookshelf.de
××™× ×˜×¨× ×˜Jan Siehl, MD Medizinische Klinik III (Hematology, Oncology and Transfusion Medicine) Charité Campus Benjamin Franklin Hindenburgdamm Berlin Germany Erich …
C-kit, GIST, and Imatinib | SpringerLinklink.springer.com › Targeted Therapies in Cancer
link.springer.com
C-kit, GIST, and Imatinib. Jan Siehl MD &; Eckhard Thiel MD PhD. Chapter Jan Siehl MD & Eckhard Thiel MD PhD. Authors. Jan Siehl MD. View author ...
C-kit, GIST, and Imatinib | SpringerLink
link.springer.com
von J Siehl · · Zitiert von: 60 — Jan Siehl MD &; Eckhard Thiel MD PhD. Chapter Accesses. 30 Citations. Part of the Recent Results in Cancer Research book series (RECENTCANCER,volume ... › chapter
Targeted Therapies in Cancer | SpringerLink
link.springer.com
From its introduction, oncological chemotherapy has been encumbered by its poor selectivity because most antiproliferative drugs are toxic not only to tumor...
Targeted Therapies in Cancer | SpringerLink
link.springer.com
von M Dietel · Zitiert von: 7 — Jan Siehl, Eckhard Thiel. Pages PDF · Antibody Therapy in Non-Hodgkin's Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, and Alemtuzumab. › book
HIV-Associated Lung Cancer - OUCIouci.dntb.gov.ua › works
ouci.dntb.gov.ua
Kiderlen, Jan Siehl, Marcus Hentrich. Abstract. Lung cancer (LC) is one of the most common non-AIDS (acquired immune deficiency syndrome)-defining ...
HIV-Associated Lung Cancer - PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Epub Feb 20. Authors. Til R Kiderlen, Jan Siehl, Marcus Hentrich. PMID: ; DOI: Abstract. Lung cancer (LC) is one of the most ...
[PPT]
www.ejcancer.com
... Jan Siehl, Michael H. Foerster, Eckhard Thiel. European Journal of Cancer. Volume 40 Issue 14 Pages (September 2004). DOI: j.ejca
Recent Results in Cancer Research PDF - ELIB.TIPS
elib.tips
Recent Results in Cancer ResearchManaging EditorsP. M. Schlag, Berlin · H.-J. Senn, St. Gallen Associate EditorsP...
Targeted Therapies in Cancer (Recent Results in EPDF.PUB
epdf.tips
C-kit, GIST, and Imatinib Jan Siehl, Eckhard Thiel Antibody Therapy in Non-Hodgkin's Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, ... › targeted-therapie...
Targeted therapies in cancer - JH Libraries
catalyst.library.jhu.edu
C-kit, GIST, and imatinib / Jan Siehl and Eckhard Thiel; 13. Antibody therapy in non-Hodgkin's lymphoma : the role of rituximab, 90Y-ibritumomab tiuxetan, and ...
Alle Infos zum Namen "Jan Siehl"
sortiert nach Relevanz / Datum